CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
administration) to reduce maintenance therapy without loss of asthma control in adolescent and adults with severe asthma..Study det...
Phase 3
London, United Kingdom and 83 other locations
in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...
Phase 3
London, United Kingdom and 83 other locations
This study will assess the efficacy and safety of dexpramipexole as an adjunctive oral therapy in participants with inadequately controlled asthma...
Phase 3
Enfield Town, United Kingdom and 125 other locations
is to investigate the safety, tolerability, and efficacy of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma...
Phase 3
High Wycombe, United Kingdom and 45 other locations
compared with placebo in participants with moderate-to-severe asthma.Study details include:* The study duration for each participant will be...
Phase 2
London, United Kingdom and 24 other locations
The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will e...
Phase 2
Chertsey, Surrey, United Kingdom and 122 other locations
12 years old with moderate to severe asthma....
Phase 2
London, United Kingdom and 20 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Enfield Town, United Kingdom and 196 other locations
The United Kingdom has a high prevalence of asthma (over 12%) and some of the worst health outcomes in Europe. The management of respiratory...
London, England, United Kingdom
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
London, United Kingdom and 115 other locations
Clinical trials
Research sites
Resources
Legal